Graphite Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Graphite Bio and buy or sell other stocks, ETFs, and their options commission-free!

About GRPH

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. 

CEO
Evert B. Schimmelpennink
CEOEvert B. Schimmelpennink
Employees
42
Employees42
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
Founded
Employees
42
Employees42

GRPH Key Statistics

Market cap
797.43M
Market cap797.43M
Price-Earnings ratio
-16.38
Price-Earnings ratio-16.38
Dividend yield
Dividend yield
Average volume
243.69K
Average volume243.69K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$38.93
52 Week high$38.93
52 Week low
$14.42
52 Week low$14.42

People also own

Based on the portfolios of people who own GRPH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.